Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 009034/0525 | |
| Pages: | 3 |
| | Recorded: | 05/13/1998 | | |
| Conveyance: | SEE RECORDING AT REEL 9039, FRAME 0487. (RE-RECORDED TO CORRECT THE RECORDATION DATE OF 02-23-98 TO 02-23-96) |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/17/1998
|
Application #:
|
08606176
|
Filing Dt:
|
02/23/1996
|
|
Title:
|
METHOD FOR TREATING SENSORINEURAL HEARING LOSS USING GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR (GDNF) PROTEIN PRODUCT
|
|
|
Assignee
|
|
|
|
|
| AMGEN CENTER |
| 1840 DEHAVILLAND DRIVE |
| THOUSAND OAKS, CALIFORNIA 91320 |
|
|
Correspondence name and address
|
| |
AMGEN INC.
|
| |
DANIEL R. CURRY
|
| |
U.S. PATENT OPERATIONS/DRC
|
| |
1840 DEHAVILLAND DRIVE
|
| |
THOUSAND OAKS, CA 91320-1789
|
Search Results as of:
05/05/2024 04:04 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
